163 related articles for article (PubMed ID: 7408260)
1. Failure to show a correlation between serum parathyroid hormone, nerve conduction velocity and serum lipids in hemodialysis patients.
Schaefer K; Offermann G; von Herrath D; Schröter R; Stölzel R; Arntz HR
Clin Nephrol; 1980 Aug; 14(2):81-8. PubMed ID: 7408260
[TBL] [Abstract][Full Text] [Related]
2. Search for the uremic toxin. Decreased motor-nerve conduction velocity and elevated parathyroid hormone in uremia.
Avram MM; Feinfeld DA; Huatuco AH
N Engl J Med; 1978 May; 298(18):1000-3. PubMed ID: 205786
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
Chudek J; Piecha G; Kokot F; Wiecek A
J Nephrol; 2003; 16(5):710-5. PubMed ID: 14733418
[TBL] [Abstract][Full Text] [Related]
5. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
6. The comparison of low flow (QD 200) to regular flow QD 500) dialysis.
Rattazzi T; Wathen R; Comty C; Raij L; Leonard A; Shapiro F
Trans Am Soc Artif Intern Organs; 1974; 20A():402-8. PubMed ID: 4450363
[No Abstract] [Full Text] [Related]
7. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
8. The beneficial effect of ketoacids on serum phosphate and parathyroid hormone in patients with chronic uremia.
Schaefer K; von Herrath D; Asmus G; Umlauf E
Clin Nephrol; 1988 Aug; 30(2):93-6. PubMed ID: 3180519
[TBL] [Abstract][Full Text] [Related]
9. Serum ionized calcium, parathyroid hormone and phosphate in uremic patients during and between hemodialysis.
Rudnicki M; Frølich A; Haaber A; Tvedegaard E; Thode J
Clin Nephrol; 1993 Oct; 40(4):225-9. PubMed ID: 8261680
[TBL] [Abstract][Full Text] [Related]
10. Relationship between serum parathyroid hormone levels and lipid profile in hemodialysis patients. Evolution of lipid parameters after parathyroidectomy.
Navarro JF; Teruel JL; Lasunción MA; Mora-Fernandez C; Ortuño J
Clin Nephrol; 1998 May; 49(5):303-7. PubMed ID: 9617494
[TBL] [Abstract][Full Text] [Related]
11. [Acute effects of hemodialysis on circulating parathormone, osteocalcin and alkaline phosphatase in patients with chronic renal failure].
Broulík P; Hrubý M
Cas Lek Cesk; 1993 Nov; 132(22):681-3. PubMed ID: 8293434
[TBL] [Abstract][Full Text] [Related]
12. Severe proximal myopathy in advanced renal failure. Diagnosis and management.
Adeniyi O; Agaba EI; King M; Servilla KS; Massie L; Tzamaloukas AH
Afr J Med Med Sci; 2004 Dec; 33(4):385-8. PubMed ID: 15977450
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral calcitriol pulse therapy on the lipid, calcium, and glucose homeostasis of hemodialysis-patients: its safety in a combination with oral calcium carbonate.
Khajehdehi P; Taheri S
J Ren Nutr; 2003 Apr; 13(2):78-83. PubMed ID: 12671829
[TBL] [Abstract][Full Text] [Related]
14. Long-term effect of different dialysate calcium concentrations on parathyroid hormone levels in hemodialysis patients.
Hwang JC; Chen CA; Wang CT; Chen HC
Ren Fail; 2008; 30(10):943-51. PubMed ID: 19016144
[TBL] [Abstract][Full Text] [Related]
15. The effect of lowering the serum phosphate on parathyroid hormone secretion and total serum calcium during regular hemodialysis.
Hill AV; Thein-Than ; Cook DB; Derr KN; Latner AL
Clin Nephrol; 1973; 1(5):284-9. PubMed ID: 4797465
[No Abstract] [Full Text] [Related]
16. [Chronic kidney disease (CKD) and bone. Targets of serum calcium, phosphate, and parathyroid hormone levels and their controls in maintenance dialysis patients].
Akiba T
Clin Calcium; 2009 Apr; 19(4):537-44. PubMed ID: 19329833
[TBL] [Abstract][Full Text] [Related]
17. The effect of parathyroid hormone and 1,25 (OH)2D3 on nerve conductance in patients on maintenance hemodialysis.
Ivić MA; Kostić S; Strahinjić S; Stefanović V
Acta Med Iugosl; 1989; 43(5):349-55. PubMed ID: 2626971
[TBL] [Abstract][Full Text] [Related]
18. Serum osteoprotegerin level is lower in peritoneal dialysis patients than in hemodialysis ones.
Grzegorzewska AE; Młot M
Rocz Akad Med Bialymst; 2004; 49():193-6. PubMed ID: 15631342
[TBL] [Abstract][Full Text] [Related]
19. Spermatogenesis after parathyroidectomy in patients with symptomatic secondary hyperparathyroidism.
Chou FF; Lee CH; Lee CT; Huang FJ; Hsu KL
J Am Coll Surg; 2003 Jun; 196(6):854-8. PubMed ID: 12788420
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of phosphate-binders in patients on regular hemodialysis (author's transl)].
Gahl G; Hopfenmüller W; Baethke R
Med Klin; 1978 May; 73(19):710-4. PubMed ID: 651760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
